{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:12:29Z","timestamp":1790194349876,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRA-POR-2-14-647"],"award-info":[{"award-number":["HRA-POR-2-14-647"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRA_POR\/2011\/23"],"award-info":[{"award-number":["HRA_POR\/2011\/23"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRA_POR\/2012\/32"],"award-info":[{"award-number":["HRA_POR\/2012\/32"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["613979"],"award-info":[{"award-number":["613979"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["FP7-KBBE-2013-7"],"award-info":[{"award-number":["FP7-KBBE-2013-7"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI\/12\/RC\/2273"],"award-info":[{"award-number":["SFI\/12\/RC\/2273"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["201 714"],"award-info":[{"award-number":["201 714"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007\u20132013"],"award-info":[{"award-number":["FP7\/2007\u20132013"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["20771"],"award-info":[{"award-number":["20771"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jpsychires.2018.02.011","type":"journal-article","created":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T07:23:54Z","timestamp":1518247434000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy"],"prefix":"10.1016","volume":"100","author":[{"given":"A.P.","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Naughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4983-7912","authenticated-orcid":false,"given":"R.","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6962-9128","authenticated-orcid":false,"given":"G.","family":"Shorten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4574-2799","authenticated-orcid":false,"given":"D.M.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5887-2723","authenticated-orcid":false,"given":"J.F.","family":"Cryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.G.","family":"Dinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2018.02.011_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neubiorev.2016.12.006","article-title":"A systematic review of the psychobiological burden of informal caregiving for patients with dementia: focus on cognitive and biological markers of chronic stress","volume":"73","author":"Allen","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2015.06.033","article-title":"Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT","volume":"186","author":"Allen","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neubiorev.2015.01.018","article-title":"Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response","volume":"51","author":"Andrews","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuropharm.2015.11.015","article-title":"Tryptophan availability for kynurenine pathway metabolism across the life span: control mechanisms and focus on aging, exercise, diet and nutritional supplements","volume":"112","author":"Badawy","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.02.011_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1192\/bjp.187.2.148","article-title":"Acute tryptophan depletion as a model of depressive relapse","volume":"187","author":"Booij","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"6349","key":"10.1016\/j.jpsychires.2018.02.011_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan's metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.02.011_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-9-6","article-title":"Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort","volume":"9","author":"Clarke","year":"2009","journal-title":"BMC Gastroenterol."},{"issue":"B","key":"10.1016\/j.jpsychires.2018.02.011_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuropharm.2016.08.029","article-title":"The kynurenine pathway in health and disease","volume":"112","author":"Clarke","year":"2017","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.jpsychires.2018.02.011_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib10","first-page":"29","article-title":"Resting-state connectivity biomarkers define neurophysiological subtypes of depression","volume":"23","author":"Drysdale","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2015.02.029","article-title":"The impact of electroconvulsive therapy on the tryptophan\u2013kynurenine metabolic pathway","volume":"48","author":"Guloksuz","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.02.011_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/YCT.0000000000000127","article-title":"The immune system and electroconvulsive therapy for depression","volume":"30","author":"Guloksuz","year":"2014","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2018.02.011_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neubiorev.2016.02.011","article-title":"Molecular biomarkers of depression","volume":"64","author":"Gururajan","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8","key":"10.1016\/j.jpsychires.2018.02.011_bib15","doi-asserted-by":"crossref","first-page":"e862","DOI":"10.1038\/tp.2016.131","article-title":"MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c","volume":"6","author":"Gururajan","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.02.011_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","article-title":"Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression","volume":"17","author":"Haile","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.02.011_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1037\/a0018555","article-title":"The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review","volume":"78","author":"Hofmann","year":"2010","journal-title":"J. Consult. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.02.011_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/appi.ajp.2014.14020138","article-title":"The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry","volume":"171","author":"Insel","year":"2014","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.02.011_bib19","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","article-title":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","volume":"4","author":"Kalsi","year":"2011","journal-title":"Emerg. Health Threats J."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib20","article-title":"Dimensional thinking in psychiatry in the era of the research domain criteria (RDoC)","author":"Kelly","year":"2017","journal-title":"Ir. J. Psychol. Med."},{"issue":"8","key":"10.1016\/j.jpsychires.2018.02.011_bib21","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00213-014-3767-z","article-title":"Acute tryptophan depletion reduces kynurenine levels: implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome","volume":"232","author":"Kennedy","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2018.02.011_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","article-title":"Kynurenine pathway metabolism and the microbiota-gut-brain axis","volume":"112","author":"Kennedy","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.02.011_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/bja\/aev135","article-title":"Effect of subanaesthetic ketamine on plasma and saliva cortisol secretion","volume":"115","author":"Khalili-Mahani","year":"2015","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2015.06.008","article-title":"The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression","volume":"64","author":"Kim","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.02.011_bib63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2014.02.017","article-title":"Do the dissociative side effects of ketamine mediate its antidepressant effects?","volume":"159","author":"Luckenbaugh","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.jpsychires.2018.02.011_bib26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.jpsychires.2018.02.011_bib27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/npp.2013.140","article-title":"Conceptual confluence: the kynurenine pathway as a common target for ketamine and the convergence of the inflammation and glutamate hypotheses of depression","volume":"38","author":"Miller","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.jpsychires.2018.02.011_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.02.011_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","article-title":"A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action","volume":"156","author":"Naughton","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jpsychires.2018.02.011_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hup.609","article-title":"Cytokines: abnormalities in major depression and implications for pharmacological treatment","volume":"19","author":"O'Brien","year":"2004","journal-title":"Hum. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.02.011_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/mp.2011.162","article-title":"Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression","volume":"17","author":"O'Connor","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.02.011_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2, 3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2015.12.004","article-title":"Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders","volume":"112","author":"O'Farrell","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2018.02.011_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2014.07.046","article-title":"Faster, better, stronger: towards new antidepressant therapeutic strategies","volume":"753","author":"O'Leary","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.jpsychires.2018.02.011_bib36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpsychires.2016.09.025","article-title":"Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression","volume":"84","author":"Park","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib38","first-page":"842817","article-title":"Ketamine, transcranial magnetic stimulation, and depression specific yoga and mindfulness based cognitive therapy in management of treatment resistant depression: review and some data on efficacy","volume":"2015","author":"Pradhan","year":"2015","journal-title":"Depress. Res. Treat"},{"issue":"8","key":"10.1016\/j.jpsychires.2018.02.011_bib39","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/ajp.153.8.985","article-title":"Resistance to antidepressant medications and short-term clinical response to ECT","volume":"153","author":"Prudic","year":"1996","journal-title":"Am. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.02.011_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0165-1781(90)90098-P","article-title":"Medication resistance and clinical response to electroconvulsive therapy","volume":"31","author":"Prudic","year":"1990","journal-title":"Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.02.011_bib41","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0306-4530(02)00108-7","article-title":"Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change","volume":"28","author":"Pruessner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.02.011_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.02.011_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0019-5545.82567","article-title":"Antidepressants: from MAOIs to SSRIs and more","volume":"53","author":"Ramachandraih","year":"2011","journal-title":"Indian J. Psychiatr."},{"issue":"20","key":"10.1016\/j.jpsychires.2018.02.011_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: medical implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expet Rev. Mol. Med."},{"issue":"10","key":"10.1016\/j.jpsychires.2018.02.011_bib45","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.285.10.1299","article-title":"Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial","volume":"285","author":"Sackeim","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.02.011_bib46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00004714-199004000-00004","article-title":"The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression","volume":"10","author":"Sackeim","year":"1990","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.02.011_bib47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.02.011_bib62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00406-016-0722-5","article-title":"The sex-dependent role of the glucocorticoid receptor in depression: variations in the NR3C1 gene are associated with major depressive disorder in women but not in men","volume":"267","author":"Sarubin","year":"2017","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.02.011_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-016-0517-7","article-title":"Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients","volume":"13","author":"Schwieler","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.jpsychires.2018.02.011_bib50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1176\/appi.ajp.2015.15030372","article-title":"Bitemporal versus high-dose unilateral twice-weekly electroconvulsive therapy for depression (EFFECT-Dep): a pragmatic, randomised, non-inferiority trial","volume":"173","author":"Semkovska","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib51","article-title":"Side-effects associated with ketamine use in depression: a systematic review","author":"Short","year":"2017","journal-title":"Lancet Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2018.02.011_bib52","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jad.2017.06.052","article-title":"The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls","volume":"222","author":"Sorgdrager","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.psyneuen.2015.10.010","article-title":"Assessment of the cortisol awakening response: expert consensus guidelines","volume":"63","author":"Stalder","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.jpsychires.2018.02.011_bib55","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbi.2011.05.002","article-title":"Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder","volume":"25","author":"Sublette","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.02.011_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatr."},{"issue":"9360","key":"10.1016\/j.jpsychires.2018.02.011_bib57","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"U.K. ECT Review Group","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2018.02.011_bib58","series-title":"Depression. Fact Sheet","author":"World Health Organisation","year":"2016"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.02.011_bib59","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","article-title":"Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression","volume":"77","author":"Yang","year":"2015","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.011_bib60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jpsychires.2018.02.011_bib61","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatr."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395617310877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395617310877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T01:29:34Z","timestamp":1656034174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395617310877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":62,"alternative-id":["S0022395617310877"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.02.011","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}